| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-09-06 20:26:42 UTC |
|---|
| Updated at | 2022-09-06 20:26:42 UTC |
|---|
| NP-MRD ID | NP0237331 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (9z)-n-[(2s,3r,4e)-1,3-dihydroxyoctadec-4-en-2-yl]octadec-9-enimidic acid |
|---|
| Description | Ceramide (d18:1/9Z-18:1), Also known as C18:1 Cer or N-(9Z-octadecenoyl)-ceramide, belongs to the class of organic compounds known as long-chain ceramides. These are ceramides bearing a long chain fatty acid. Thus, ceramide (D18:1/9Z-18:1) Is considered to be a ceramide lipid molecule. Ceramide (d18:1/9Z-18:1) Is a very hydrophobic molecule, practically insoluble (in water), and relatively neutral. A Ceramide (d18:1/9Z-18:1) In which the ceramide N-acyl group is specified as oleoyl. (9z)-n-[(2s,3r,4e)-1,3-dihydroxyoctadec-4-en-2-yl]octadec-9-enimidic acid is found in Trypanosoma brucei. (9z)-n-[(2s,3r,4e)-1,3-dihydroxyoctadec-4-en-2-yl]octadec-9-enimidic acid was first documented in 1994 (PMID: 8163674). Ceramide (d18:1/9Z-18:1), With regard to humans, has been found to be associated with the diseases such as colorectal cancer; ceramide (D18:1/9Z-18:1) Has also been linked to the inborn metabolic disorder fabry disease (PMID: 14722105) (PMID: 9545298) (PMID: 15067322) (PMID: 14693694). |
|---|
| Structure | [H][C@@](CO)(NC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC InChI=1S/C36H69NO3/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-36(40)37-34(33-38)35(39)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,29,31,34-35,38-39H,3-16,19-28,30,32-33H2,1-2H3,(H,37,40)/b18-17-,31-29+/t34-,35+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| C18:1 Cer | ChEBI | | Cer(d18:1/18:1(9Z)) | ChEBI | | N-(9Z-Octadecenoyl)-ceramide | ChEBI | | N-(9Z-Octadecenoyl)-sphing-4-enine | ChEBI | | N-(Oleoyl)-ceramide | ChEBI | | N-[(9Z)-Octadecenoyl]sphing-4-enine | ChEBI | | N-[(9Z)-Octadecenoyl]sphingosine | ChEBI | | N-Oleoylsphing-4-enine | ChEBI | | (2S,3R,4E)-2-acylamino-1,3-Octadec-4-enediol | HMDB | | (2S,3R,4E)-2-Acylaminooctadec-4-ene-1,3-diol | HMDB | | Cer | HMDB | | Ceramide | HMDB | | N-Acylsphingosine | HMDB | | N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-octadecanamide | HMDB | | N-Oleoylsphingosine | MeSH, HMDB | | Oleoylsphingosine | MeSH, HMDB | | C18:1-Ceramide | HMDB | | Cer d18:1/18:1 | HMDB | | Cer d18:1/18:1(9Z) | HMDB | | Cer(d18:1/18:1) | HMDB | | Ceramide (d18:1,C18:1(9Z)) | HMDB | | Ceramide (d18:1/18:1(9Z)) | HMDB | | Ceramide (d18:1/18:1) | HMDB | | Ceramide (d18:1/9Z-18:1) | HMDB | | Ceramide 18:1 | HMDB | | Ceramide(d18:1/18:1(9Z)) | HMDB | | Ceramide(d18:1/18:1) | HMDB | | Ceramide(d18:1/9Z-18:1) | HMDB | | D-erythro-1,3-Dihydroxy-2-(cis-9-octadecenoylamido)-trans-4-octadecene | HMDB | | N-Oleoyl-4-sphingenine | HMDB | | N-Oleoyl-D-sphingosine | HMDB |
|
|---|
| Chemical Formula | C36H69NO3 |
|---|
| Average Mass | 563.9380 Da |
|---|
| Monoisotopic Mass | 563.52775 Da |
|---|
| IUPAC Name | (9Z)-N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]octadec-9-enamide |
|---|
| Traditional Name | N-(oleoyl)-ceramide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](CO)(NC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC |
|---|
| InChI Identifier | InChI=1S/C36H69NO3/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-36(40)37-34(33-38)35(39)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,29,31,34-35,38-39H,3-16,19-28,30,32-33H2,1-2H3,(H,37,40)/b18-17-,31-29+/t34-,35+/m0/s1 |
|---|
| InChI Key | OBFSLMQLPNKVRW-RHPAUOISSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, H2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as long-chain ceramides. These are ceramides bearing a long chain fatty acid. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Sphingolipids |
|---|
| Sub Class | Ceramides |
|---|
| Direct Parent | Long-chain ceramides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Long-chain ceramide
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Carboxamide group
- Secondary alcohol
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Alcohol
- Organic nitrogen compound
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Deguchi H, Yegneswaran S, Griffin JH: Sphingolipids as bioactive regulators of thrombin generation. J Biol Chem. 2004 Mar 26;279(13):12036-42. Epub 2004 Jan 13. [PubMed:14722105 ]
- Watanabe R, Wu K, Paul P, Marks DL, Kobayashi T, Pittelkow MR, Pagano RE: Up-regulation of glucosylceramide synthase expression and activity during human keratinocyte differentiation. J Biol Chem. 1998 Apr 17;273(16):9651-5. doi: 10.1074/jbc.273.16.9651. [PubMed:9545298 ]
- Mari M, Colell A, Morales A, Paneda C, Varela-Nieto I, Garcia-Ruiz C, Fernandez-Checa JC: Acidic sphingomyelinase downregulates the liver-specific methionine adenosyltransferase 1A, contributing to tumor necrosis factor-induced lethal hepatitis. J Clin Invest. 2004 Mar;113(6):895-904. doi: 10.1172/JCI19852. [PubMed:15067322 ]
- Adams JM 2nd, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, Mandarino LJ: Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes. 2004 Jan;53(1):25-31. doi: 10.2337/diabetes.53.1.25. [PubMed:14693694 ]
- Holleran WM, Ginns EI, Menon GK, Grundmann JU, Fartasch M, McKinney CE, Elias PM, Sidransky E: Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease. J Clin Invest. 1994 Apr;93(4):1756-64. doi: 10.1172/JCI117160. [PubMed:8163674 ]
- LOTUS database [Link]
|
|---|